Left Menu
Development News Edition

Lupin launches generic hypokalemia drug in US

PTI | New Delhi | Updated: 19-11-2019 16:07 IST | Created: 19-11-2019 15:20 IST
Lupin launches generic hypokalemia drug in US
Representative image Image Credit: ANI

Pharma firm Lupin on Tuesday said it has launched in the US generic potassium chloride for the oral solution used for treatment and prevention of hypokalemia. The company had earlier received approval for the product from the United States Food and Drug Administration (USFDA), Lupin said in a statement.

Lupin's potassium chloride for oral solution USP, 20 mEq, is the generic version of Pharma Research Software Solution LLC's potassium chloride for oral solution USP in the same strength, it added. As per IQVIA MAT September 2019 data, potassium chloride for oral solution USP, 20 mEq had an annual sale of around USD 90 million in the US, Lupin said.

The product "is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient," it added. Shares of Lupin were trading at Rs 747 per scrip on the BSE, up 0.09 percent from the previous close.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Smart healthcare: IoT redefining the way healthcare is delivered

As the world is embracing the new wave of digitalization triggered by the pandemic and the arrival of 5G, the adoption of IoT devices will further boom. With adoption set to soar, IoT security issues and other challenges cant be ignored any...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

‘Real hope’ over COVID vaccines ‘cannot be overstated’ – WHO chief

With the latest positive news from vaccine trials, the light at the end of this long, dark tunnel is growing brighter, said Director-General Tedros Adhanom Ghebreyesus. The significance of this scientific achievement cannot be overstated....

Key U.S. agency says no presidential transition yet, will brief Congress

The federal agency that must sign off on the presidential transition said on Monday it had still not approved the hand-over process for President-elect Joe Biden, defying demands by Democrats, but would brief Congress on Nov. 30. A U.S. Gen...

Georgia sets timeline for Trump-requested vote recount

Georgia will begin recounting votes from the Nov. 3 election again on Tuesday at 9 a.m. EST 1400 GMT, in response to a request from President Donald Trumps campaign, a state official said.The new recount, which is not expected to alter cert...

US STOCKS-Cyclical gains lift stocks, Yellen news gives brief boost

U.S. stocks closed higher in a choppy session on Monday as hopes for a COVID-19 vaccine lifted economically sensitive sectors such as energy and industrials, but a pullback in megacap shares curbed gains on the SP 500 and Nasdaq.Cyclicals l...

Give Feedback